About Cepheid
Cepheid is a company based in Sunnyvale (United States) founded in 1996 was acquired by Danaher in September 2016. Cepheid has raised $19.1 million across 8 funding rounds from investors including Medtronic, NIH and Danaher. The company has 208 employees as of April 07, 2024. Cepheid has completed 1 acquisition, including OncoMark. Cepheid operates in a competitive market with competitors including Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences, among others.
- Headquarter Sunnyvale, United States
- Employees 208 as on 07 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cepheid India Private Limited
- Date of Incorporation 22 Aug, 2013
- Jurisdiction Gurugram, Haryana, India
-
Annual Revenue
$54.88 M (USD)10.43as on Mar 31, 2022
-
Net Profit
$7.33 M (USD)4.46as on Mar 31, 2022
-
EBITDA
$10.37 M (USD)6.35as on Mar 31, 2022
-
Total Equity Funding
$19.1 M (USD)
in 8 rounds
-
Latest Funding Round
$28 M (USD), Grant
Jul 30, 2021
-
Investors
Medtronic
& 11 more
-
Employee Count
208
as on Apr 07, 2024
- Investments & Acquisitions
-
Acquired by
Danaher
(Sep 06, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cepheid
Unlock access to complete
Software Development Team
168 people
Leadership Team
90 people
Product Management Team
59 people
Senior Team
55 people
Sales and Marketing
39 people
Operations Team
31 people
Human Resources and Administration
29 people
Finance and Accounting
24 people
Unlock access to complete
Funding Insights of Cepheid
Cepheid has successfully raised a total of $19.1M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $28 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cepheid
Cepheid has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, NIH and Danaher.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-based companies are invested in by Wheatley Partners.
|
Locked | Locked | Locked | |
|
Biotechnology investments are targeted by the venture capital firm.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked |
Investor details for Cepheid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cepheid
Cepheid has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OncoMark.
Investment portfolio details for Cepheid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Tissue-based cancer diagnostics are developed by OncoMark.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Cepheid
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Cepheid
Detailed financials for Cepheid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cepheid Comparisons
Peer comparison for Cepheid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cepheid
Cepheid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
Detailed competitors of Cepheid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cepheid
Complete news archive for Cepheid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cepheid
Cepheid was founded in 1996 and raised its 1st funding round 4 years after it was founded.
Cepheid is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Cepheid is a funded company, having raised a total of $19.1M across 8 funding rounds to date.
As of Apr 07, 2024, the latest employee count at Cepheid is 208.
Annual revenue of Cepheid is $54.88M as on Mar 31, 2022.
Cepheid was founded in 1996 in Sunnyvale, United States, within the molecular diagnostics sector. Testing solutions are provided across categories including hospital-acquired infections, critical infectious diseases such as multi-drug resistant tuberculosis, influenza, respiratory syncytial virus, and enteroviral meningitis, as well as sexual health and genetic assessments like a 30-minute test for thrombosis risk. Operations focus on healthcare applications in the United States.
Cepheid's top competitors include Blackrock Neurotech, Agilent and Esco Lifesciences.
Cepheid has made 1 acquisition, including OncoMark.